| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/08/2004 | US20040006075 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 01/08/2004 | US20040006067 Substituted piperidines and methods of use |
| 01/08/2004 | US20040006066 Ring fused pyrazole derivatives as CRF antagonists |
| 01/08/2004 | US20040006063 Dipeptide derivatives |
| 01/08/2004 | US20040006057 For therapy of connective tissue disorders, inflammatory disorders, immunology/allergy disorders, infectious diseases, respiratory diseases, cardiovascular diseases, eye diseases, metabolic diseases, central nervous system (CNS) disorders |
| 01/08/2004 | US20040006032 Vaccination |
| 01/08/2004 | US20040006022 For therapy of autoimmune or an inflammatory disease |
| 01/08/2004 | US20040005630 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 01/08/2004 | US20040005576 Comprises polypeptides for diagnosing, prognosing and preventing cancer, nervous system, developmental and metabolic disorders |
| 01/08/2004 | US20040005370 DHEA and/or a chemical or biological precursor or derivative of the latter, characterized in that it additionally comprises at least one metalloproteinase inhibitor. |
| 01/08/2004 | US20040005316 Use of HMG fragments as anti-inflammatory agents |
| 01/08/2004 | US20040005299 Method for producing pseudo islets |
| 01/08/2004 | US20040005298 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 01/08/2004 | DE10227269A1 Thiazolderivate Thiazole derivatives |
| 01/08/2004 | DE10012026B4 Verwendung eines Gels Use of a gel |
| 01/08/2004 | CA2494249A1 Novel azasugar derivative and drug containing the same as the active ingredient |
| 01/08/2004 | CA2493646A1 Caspase inhibitors and uses thereof |
| 01/08/2004 | CA2492080A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 01/08/2004 | CA2492066A1 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 01/08/2004 | CA2491034A1 Methods and materials for treating human papillomavirus infections |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490193A1 Glycoloyl-substituted oxazolidinone-derivatives as antibacterial agents |
| 01/08/2004 | CA2490016A1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 01/08/2004 | CA2489675A1 Glycoalkaloid compositions and various uses thereof |
| 01/08/2004 | CA2489560A1 Substituted quinoline ccr5 receptor antagonists |
| 01/08/2004 | CA2489376A1 Methods of organ regeneration |
| 01/08/2004 | CA2488526A1 Stable liquid parenteral parecoxib formulation |
| 01/08/2004 | CA2482745A1 Hair and nail treatments using alkanolamines |
| 01/07/2004 | EP1378573A1 Interleukin 1 beta protease and interleukin 1 beta protease inhibitors |
| 01/07/2004 | EP1378510A1 Triazaspiro 5.5]undecane derivatives and drugs containing the same as the active ingredient |
| 01/07/2004 | EP1378224A1 Sugar intake promoters |
| 01/07/2004 | EP1377611A2 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 01/07/2004 | EP1377610A2 Osteoprotegerin in milk |
| 01/07/2004 | EP1377609A2 Mhc molecule constructs and their uses for diagnosis and therapy |
| 01/07/2004 | EP1377593A2 2-amino-propanol derivatives |
| 01/07/2004 | EP1377589A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 01/07/2004 | EP1377576A2 Pyridine derivatives |
| 01/07/2004 | EP1377574A1 6-phenylbenzonaphthyridines |
| 01/07/2004 | EP1377572A1 Isoxaxole derivatives as inhibitors of src and other protein kinases |
| 01/07/2004 | EP1377571A1 Compounds for use in the treatment of skin conditions |
| 01/07/2004 | EP1377567A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 01/07/2004 | EP1377560A1 Piperazine derivatives as tachykinin antagonists |
| 01/07/2004 | EP1377558A1 [1,4]-diazepane-1-carboxylic acid derivatives, process for their preparation and their use as tachykinin antagonists |
| 01/07/2004 | EP1377555A1 Novel compounds |
| 01/07/2004 | EP1377553A1 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof |
| 01/07/2004 | EP1377550A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
| 01/07/2004 | EP1377540A1 INHIBITORS OF INTEGRIN AvB6 |
| 01/07/2004 | EP1377315A2 Pharmaceutical compositions |
| 01/07/2004 | EP1377291A2 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 01/07/2004 | EP1377282A2 Aryl-n-cyanoguanidines and methods related thereto |
| 01/07/2004 | EP1377276A2 Timed pulse release composition |
| 01/07/2004 | EP1377273A2 Method for producing an active ingredient concentrate, and an active ingredient concentrate |
| 01/07/2004 | EP1377269A1 Encapsulated dyes in cosmetic compositions |
| 01/07/2004 | EP1377254A2 Cosmetic and dermatological preparations comprising an isoflavone content |
| 01/07/2004 | EP1377253A1 Methods of preventing uvb-induced skin damage |
| 01/07/2004 | EP1289997B1 Macrolides |
| 01/07/2004 | EP1175417B1 Substituted benzolactam compounds |
| 01/07/2004 | EP1028741B1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 01/07/2004 | EP0943334B1 Tortoise oil, turtle oil, compositions containing them, their preparation processes and uses |
| 01/07/2004 | EP0931092B1 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 01/07/2004 | EP0600880B1 Interleukin 1- beta protease and interleukin 1-beta protease inhibitors |
| 01/07/2004 | CN1466586A Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 01/07/2004 | CN1466577A 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 01/07/2004 | CN1466576A Quinolne-(C=O)-CD1, tri-and tetrapeptide) derivatives as caspase inhibitors |
| 01/07/2004 | CN1466573A 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 01/07/2004 | CN1466569A Novel 3-substituted urea derivatives and medicinal use thereof |
| 01/07/2004 | CN1466461A Antipruritic compositions and compositions promoting wound healing |
| 01/07/2004 | CN1466458A Use of arginine in the preparation of a medicament for the prevention and treatment of the side effcts associated with the intravenous administration |
| 01/07/2004 | CN1466453A Fatty acid analogues for the treatment of proliferative skin disorders |
| 01/07/2004 | CN1465398A External collagenase ointment for treating wound |
| 01/07/2004 | CN1465383A Medical external appliation preparation containing Artemisia apiacea extract |
| 01/07/2004 | CN1465364A Ointment for curing brandy nose |
| 01/07/2004 | CN1465353A Becterin of Serratia marcescens for curing |
| 01/07/2004 | CN1465338A Skin activating composition for external used anti-aging preparation |
| 01/07/2004 | CN1465266A Health care tea for preventing and curing computer network syndrome and preparation method thereof |
| 01/07/2004 | CN1133621C Cyclohexanediole derivatives |
| 01/07/2004 | CN1133612C Bamboo parasitic fungus extract and its preparation and application |
| 01/07/2004 | CN1133465C Absorption enhancers for topical pharmaceutical formulations |
| 01/07/2004 | CN1133456C Liquid medicine for curing beriberi |
| 01/07/2004 | CN1133445C External medicine for treating neurodermatitis, intractable dermatophyte and preparation |
| 01/07/2004 | CN1133441C Medicine for treating burn |
| 01/07/2004 | CN1133438C Prepn. of polyvinylpyrrolidone ointment |
| 01/07/2004 | CN1133422C Topical application of combination of benzoyl peroxide and second active ingredient |
| 01/07/2004 | CN1133417C Method of regulating skin appearance with vitamin B3 compound |
| 01/07/2004 | CN1133416C Skin-care cosmetics containing peroxide |
| 01/07/2004 | CN1133414C Use of nanodispersions in cosmetic end formulations |
| 01/06/2004 | US6673826 Treating a skin condition or disease characterized by ulceration, inflammation, or blistering of the skin comprising applying to the skin an oil in water emulsion containing allantoin, an anionic emulsifier and beeswax |
| 01/06/2004 | US6673803 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/06/2004 | US6673798 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 01/06/2004 | US6673796 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/06/2004 | US6673794 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 01/06/2004 | US6673789 2-pyridinylguanidine urokinase inhibitors |
| 01/06/2004 | US6673777 Guanylhydrazones useful for treating diseases associated with T cell activation |
| 01/06/2004 | US6673377 Extracts derived from Pueraria mirifica, Butea superba and/or Mucuna collettii and extraction thereof |
| 01/06/2004 | US6673351 Immunotherapeutic agent comprising purified protein extract derived from killed cells of amastigotes and leishmania |
| 01/06/2004 | US6673336 Comprising an inorganic pigment and an active substance based on organic compounds being covalently bound through a group 3b,4a,4b,5b,6b spacer group to the inorganic pigment; sunscreen agents |
| 01/06/2004 | US6673124 Oxidation dyeing process and oxidation dye composition for keratin fibers which comprises a cationic amphiphilic polymer |
| 01/06/2004 | US6673054 Vitamin incorporated into thermoplastic material |
| 01/06/2004 | CA2309717C Treatment of scar tissue using lipoic acid |
| 01/06/2004 | CA2086681C Growth promoting agent derived from milk |